Functionally-claimed antibody patent – the Amgen v Sanofi case
Practices:Intellectual Property、Patents
Category:Others
Authors | YAMAMOTO, Osamu |
---|---|
Practice Areas | Intellectual Property Patents |
Date of publication | Issue 1 2020 |
Publication carrying this article | The Life Sciences Lawyer(P46~48) |
Publisher | CTC Legal Media |
Summary
Mr. Yamamoto analyzes the functionally-claimed antibody patent cases between Amgen and Sanofi in Japan.
Other works by YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Cases
Antibody Patenting – Second Edition –
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
Pharmaceutical Test Data Exclusivity
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
IP law in Japan : the recent changes
YAMAMOTO, Osamu
-
Publications
2022 – Study Question “Patentability of Diagnostic Methods”
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Others
Japanese version of “Amicus Curiae”
YAMAMOTO, Osamu
Other works on Intellectual Property、Patents
-
Publications Intellectual Property Laws、Others
Is Japan Still a Machine Learning Paradise?
OKAMOTO, Yoshinori
-
Publications Copyright Law、Intellectual Property、Patents Laws
Copyrightability and Patentability of AI-Generated Output
FUKAI, Toshiyuki
-
Publications Intellectual Property、Trademarks Laws
Assessment of Similarity with a Composite Trademark
FUKAI, Toshiyuki
-
Publications General Corporate、Intellectual Property
Responsibility of online marketplaces for online infringement of industrial property right
SUEYOSHI, Tsuyoshi
-
Publications Copyright Law、Intellectual Property Laws
Copyrightability of a Computer Program
FUKAI, Toshiyuki
Telephone
+81(3)3270-6641